Health Industry Archives - Page 104 of 200

Podcast: KHN’s ‘What The Health?’ What’s Next For The FDA?

Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.

March 7, 2019

Hidden Harm

Hidden FDA Reports Detail Harm Caused By Scores Of Medical Devices

The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.

By Christina Jewett

March 7, 2019

Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs

The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.

By Phil Galewitz

March 6, 2019

Pre$cription for Power

Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.

By Sydney Lupkin, Elizabeth Lucas, and Victoria Knight

March 4, 2019

Texas Lawmakers Take Aim At Surprise Medical Bills

A proposed state law with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills — instead of relying on patients to start the mediation process. The KHN/NPR "Bill of the Month" series is a catalyst for the effort.

By Ashley Lopez, KUT

March 1, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

March 1, 2019

Watch: Big Week For Drug Pricing Debate Featured On C-SPAN

KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.

March 1, 2019

Medicare Trims Payments To 800 Hospitals, Citing Patient Safety Incidents

The penalties are part of a program set up by the Affordable Care Act to prompt hospitals to pay more attention to safety issues that can lead to injuries, such as falls or hospital-acquired infections.

By Jordan Rau

March 1, 2019

Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay

Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.

Feb. 28, 2019

Bill Of The Month

Meow-ch! The $48,512 Cat Bite

An animal lover stopped to feed a hungry-looking stray cat outside Everglades National Park in Florida. First, the cat bit her finger — then the hospital billed her close to $50,000 for a treatment that typically costs about $3,000.

By Julie Appleby

Feb. 27, 2019

Bill Of The Month

Cancer’s Complications: Confusing Bills, Maddening Errors And Endless Phone Calls

Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.

By Anna Gorman

Feb. 27, 2019

Pharma Execs Dig In For A Fight Against Outraged Senators

The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.

By Emmarie Huetteman and Jay Hancock

Feb. 26, 2019

Video: High Drama No Stranger At Congressional Health Care Hearings

Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.

By Julie Rovner and Mary Agnes Carey

Feb. 25, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 22, 2019

Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago

Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.

By Jay Hancock

Feb. 22, 2019

Today’s Concerns About Drug Prices Echo The Past

Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.

Feb. 22, 2019

Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?

Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.

Feb. 21, 2019

For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It

Support for “Medicare-for-all” is becoming a front-runner topic among Democratic presidential candidates. But the phrase is being used to describe any number of policies.

By Shefali Luthra

Feb. 19, 2019